Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions

Recruiting Observational Study
Lung Cancer, Non-Small Cell Lung Infection
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
Peking University Cancer Hospital & Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. 18-75 years old, male or female; 2. Heart function is normal; 3. Normal heart function; 4. Estimated survival ≥12 weeks; 5. Good follow-up compliance; 6. presence of at least one measurable target lesion according to RECIST1.1 criteria; 7. Women of childbearing age (15-49 yea…
Contacts

Nan Li

+86-13693090647

rainbow6283@sina.com

CONTACT

Xin Zhou, MD

zhouxinbjmu@163.com

CONTACT